Availability: In Stock
Icp-Ich Monogram On Advances In Hemato-Oncology
Rated 3.89 out of 5 based on 9 customer ratings
9
SKU: 9789356967717
₹1,295.00 Original price was: ₹1,295.00.₹1,036.00Current price is: ₹1,036.00.
Transforming Hemato-Oncology: Explore advancements in diagnosis, risk stratification, and therapy selection for hematological malignancies. This ICP-ICH e-Monogram delves into MRD/PET-CT evaluations, molecular investigations, and Allo BMT’s curative potential. Ideal for postgraduates seeking insights into cutting-edge hematology-oncology practices. ISBN: 9789356967717
5 in stock
Shubhkirti Singh –
A mixed bag. Some chapters were excellent, others felt rushed. Good coverage of diagnostic techniques. It is an essential guide for the residents and fellows.
Sidhant Sripal –
Comprehensive and up-to-date. I appreciated the focus on MRD/PET-CT evaluations. I wish there had been more on pediatric cases though. Easy to understand.
Parth Kimta –
Excellent resource for postgraduates! The insights into molecular investigations were particularly helpful. Could have used more real-world case studies. I recommend to all!
Yatharth Bhardwaj Bhardwaj –
Informative, but a bit dense in some areas. The Allo BMT section was very well done. Overall, a valuable addition to my library. It’s an easy recommendation.
Shreya Garg –
A decent overview, but felt some sections lacked depth. Good for a quick refresher. Some topics were not discussed thoroughly. Still a worthwhile read.
Sunny B Joseph –
A valuable resource for understanding current hemato-oncology practices. It can be useful. The MRD section stood out. But, could have used more clarity.
Anurag Srivastava –
This monogram provided a solid foundation. I found the therapy selection information very useful. I think it’s well made book. I appreciate the hard work.
Swikriti Toppo –
Incredibly useful for my studies! The molecular investigation content was superb. I wish there were more visual aids. I think the book it is nice.
Princi Rai –
Good starting point for understanding advances in hemato-oncology. Some chapters were better written than others. It has a good focus on risk stratification.